Effect of an Investigational Multi-Purpose Solution on Lens Moisture

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT01341990
Collaborator
(none)
68
1
2
2
33.9

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate the effect of an investigational multi-purpose disinfecting solution (MPDS) compared to a marketed multi-purpose solution on the moisture of silicone hydrogel contact lenses.

Condition or Disease Intervention/Treatment Phase
  • Device: FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
  • Device: ReNu Fresh Lens Comfort Multi-Purpose Solution (MPS)
  • Device: Silicone Hydrogel Contact Lenses
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Effect of SiH MPDS FID 114675A vs. a Marketed Multi-Purpose Solution on Lens Moisture
Study Start Date :
Nov 1, 2009
Actual Primary Completion Date :
Jan 1, 2010
Actual Study Completion Date :
Jan 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: FID 114675A

Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses

Device: FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
Investigational solution intended for use as a cleaning, rinsing, reconditioning, disinfecting, and storage solution for silicone hydrogel and soft contact lenses

Device: Silicone Hydrogel Contact Lenses
Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).
Other Names:
  • Acuvue® Oasys™
  • PureVision®
  • Active Comparator: ReNu MultiPlus

    Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses

    Device: ReNu Fresh Lens Comfort Multi-Purpose Solution (MPS)
    Commercially marketed prodouct indicated for cleaning, removing protein deposits, rinsing, disinfecting, and storing soft contact lenses
    Other Names:
  • ReNu MultiPlus® Multi-Purpose Solution Fresh Lens Comfort™
  • Device: Silicone Hydrogel Contact Lenses
    Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).
    Other Names:
  • Acuvue® Oasys™
  • PureVision®
  • Outcome Measures

    Primary Outcome Measures

    1. Mean Ex-Vivo Advancing Contact Angle [Day 1, 8 hours]

      Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

    2. Mean Ex-Vivo Advancing Contact Angle [Day 8, 16 hours]

      Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years of age or older.

    • Wears silicone hydrogel contact lenses on a daily wear basis i.e. disinfects lenses every night).

    • Has successfully worn contact lenses for 5 days, 8 hours per day, prior to baseline visit.

    • Vision is correctable to 20/30 or better in each eye at distance with study lenses at baseline visit.

    • Other protocol-specified inclusion criteria may apply.

    Exclusion Criteria:
    • Known sensitivity or intolerance to contact lens multi-purpose solutions.

    • Use of any topical ocular OTC or prescribed topical ocular medications.

    • History or current ocular infections or ocular inflammatory events.

    • Ocular surgery within the past year.

    • Medical condition or use of medication that cause ocular side effects.

    • Participation in any investigational study within the past 30 days.

    • Other protocol-defined exclusion criteria may apply.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Contact Alcon Call Center for Trial Locations Fort Worth Texas United States 76134

    Sponsors and Collaborators

    • Alcon Research

    Investigators

    • Study Director: Justin R Webb, OD, Alcon Research

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01341990
    Other Study ID Numbers:
    • C-09-031
    First Posted:
    Apr 26, 2011
    Last Update Posted:
    Apr 13, 2012
    Last Verified:
    Mar 1, 2012
    Keywords provided by Alcon Research
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details Participants were recruited from 1 US study center.
    Pre-assignment Detail
    Arm/Group Title FID 114675A ReNu MultiPlus
    Arm/Group Description Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses
    Period Title: Overall Study
    STARTED 35 33
    COMPLETED 32 32
    NOT COMPLETED 3 1

    Baseline Characteristics

    Arm/Group Title FID 114675A ReNu MultiPlus Total
    Arm/Group Description Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses Total of all reporting groups
    Overall Participants 35 33 68
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    43.9
    (9.2)
    42.8
    (11.2)
    43.4
    (10.2)
    Sex: Female, Male (Count of Participants)
    Female
    23
    65.7%
    22
    66.7%
    45
    66.2%
    Male
    12
    34.3%
    11
    33.3%
    23
    33.8%
    Region of Enrollment (participants) [Number]
    United States
    35
    100%
    33
    100%
    68
    100%

    Outcome Measures

    1. Primary Outcome
    Title Mean Ex-Vivo Advancing Contact Angle
    Description Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.
    Time Frame Day 1, 8 hours

    Outcome Measure Data

    Analysis Population Description
    Intent to Treat.
    Arm/Group Title FID 114675A ReNu MultiPlus
    Arm/Group Description Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses
    Measure Participants 34 32
    Mean (Standard Deviation) [Degrees]
    56.7
    (21.2)
    59.2
    (23.7)
    2. Primary Outcome
    Title Mean Ex-Vivo Advancing Contact Angle
    Description Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.
    Time Frame Day 8, 16 hours

    Outcome Measure Data

    Analysis Population Description
    Intent to treat.
    Arm/Group Title FID 114675A ReNu MultiPlus
    Arm/Group Description Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses
    Measure Participants 31 32
    Mean (Standard Deviation) [Degrees]
    59.5
    (21.2)
    63.4
    (17.5)

    Adverse Events

    Time Frame Adverse events were collected for the duration of the study: 23 Nov 2009 to 27 Jan 2010.
    Adverse Event Reporting Description
    Arm/Group Title FID 114675A ReNu MultiPlus
    Arm/Group Description Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses
    All Cause Mortality
    FID 114675A ReNu MultiPlus
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    FID 114675A ReNu MultiPlus
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/35 (0%) 0/33 (0%)
    Other (Not Including Serious) Adverse Events
    FID 114675A ReNu MultiPlus
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/35 (0%) 0/33 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Director of Alcon Clinical
    Organization Alcon Research, Ltd.
    Phone 1-888-451-3937
    Email medinfo@alconlabs.com
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01341990
    Other Study ID Numbers:
    • C-09-031
    First Posted:
    Apr 26, 2011
    Last Update Posted:
    Apr 13, 2012
    Last Verified:
    Mar 1, 2012